
FAQs on the Mo-99 Manufacturing Facility
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
Showing 341 - 360 of 882 results
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
The instrument is designed to measure inelastic neutron scattering, or do neutron spectroscopy.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.
ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste.
Australia part of global renaissance in fusion power research symbolised by ITER experiment
Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.
A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.
Commitment to undertake health research.
In partnership with the Australian Museum as part of National Science Week explore the 2020 hackathon theme of Deep Blue: Innovation for the future of our oceans
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023
Nuclear techniques used in investigation of a new class of micro and nanoscale zinc fertilisers.